'Mad Money' Lightning Round: Be Patient With Zynga
at The Street - 29 mins ago
Cramer like Energy Transfer Partner's yield, would buy Kinder Morgan Energy Partners but thinks Pfizer is problematic.
Jim Cramer's 'Mad Money' Recap: This, Too, Shall Pass
at The Street - Thu Jul 31, 7:24PM CDT
Even Cramer says there's not much to like in the markets just yet because the best stocks still aren't down low enough to be attractive.
Baxter International Falls as Pfizer Acquires Vaccines - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 5:06PM CDT
The fall in Baxter International (BAX) shares is justified as the company has revealed that it expects the deal to mar its fourth quarter earnings and lower 2015 earnings by roughly 15 cents per share
Most active New York Stock Exchange-traded stocks
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Thu Jul 31, 12:34PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Next Support Level for Pfizer (PFE) is $28.77
Comtex SmarTrend(R) - Thu Jul 31, 11:41AM CDT
Pfizer (NYSE
3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:44AM CDT
These stocks are well positioned in today’s market environment.
Tax Inversion: Boon for Firms & Investors, Bane for U.S. Treasury - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:41AM CDT
The U.S. Treasury may lose $19.5 billion over the next decade due to tax inversion.
Early Glance: Pharmaceuticals companies
AP - Thu Jul 31, 9:37AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer
PR Newswire - Thu Jul 31, 8:10AM CDT
Today, Analysts Review released its research reports regarding Wells Fargo & Co. (NYSE: WFC), JPMorgan Chase & Co. (NYSE: JPM), Citigroup Inc. (NYSE: C), Regions Financial Corp. (NYSE: RF) and Pfizer Inc. (NYSE: PFE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5304-100free.
Pfizer to buy portfolio of marketed vaccines for USD635m
M2 - Thu Jul 31, 6:04AM CDT
Science company Pfizer (NYSE
Asian markets drift after US Fed stays course
By KAY JOHNSON - AP - Wed Jul 30, 11:37PM CDT
MUMBAI, India (AP) — Asian stock markets were uninspired by an upbeat report on the U.S. economy, with most drifting lower Thursday after the U.S. Federal Reserve said it would make further cuts to its monetary stimulus as expected.
Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Jul 30, 1:00PM CDT
Though the major industry players beat on earnings, performances have been mixed, pushing down pharma ETFs.
Pfizer buying two Baxter vaccines for $635M
AP - Wed Jul 30, 11:39AM CDT
NEW YORK (AP) — Pfizer will spend $635 million on two vaccines owned by Baxter International that are sold in a number of European countries and other locations outside of the U.S.
Dow Today: Pfizer (PFE) Lower
at The Street - Wed Jul 30, 11:00AM CDT
Holding back the Dow today is Pfizer (NYSE: PFE ), which is lagging the broader Dow index with a 32-cent decline (-1.1%) bringing the stock to $29.14.
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
at The Street - Wed Jul 30, 10:05AM CDT
Amgen's reallocation of resources is not quieting critics who want a bigger restructuring.
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
M2 - Wed Jul 30, 9:58AM CDT
Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a total cash consideration of $635 million, subject to certain adjustments.